(lp0
S'6.03 MarketWatch - Apr 21, 2011 Oramed Pharmaceuticals Inc. Watchlist CreateORMPAlert. Closed. Last Updated: Mar 16, 2017 3:59 p.m.. $ 6.03. -0.07 -1.15%.'
p1
aS'Oramed: The Atypical Biotechnology Company With Great Upside Potential Seeking Alpha - Jul 1, 2016 Oramed , the biotech company involved in the research and development of orally deliverable insulin, is a great investment opportunity for investors that are looking for a growing small stock in the biotechnology industry.'
p2
aS'Oramed Pharmaceuticals Inc. ORMP  Wall Street Journal - Feb 11, 2013 Oramed Pharmaceuticals Inc. ORMP . search. View All companies. AT CLOSE 3:38 PM EST 03/10/17. $6.03 USD; 0.01 0.17%.'
p3
aS'Does Oramed Pharmaceuticals Pass The Smell Test? Seeking Alpha - May 23, 2014 First off, thank you to the M.D. and Pharma classmates who helped to explain the intricacies of the clinical trial and drug patent process.'
p4
aS'Zooming in on Stock Levels: Oramed Pharmaceuticals Inc  Baxter Review - 17 hours ago Oramed Pharmaceuticals Inc  has a current 14-day RSI reading of 40.96, the 7-day is 38.2, and the 3-day is 33.58. The RSI, or Relative Strength Index is a popular oscillating indicator among traders and investors.'
p5
aS'Unusual Activity Spotted in Oramed Pharmaceuticals Inc  Sherwood Daily - 18 hours ago Needle moving action has been spotted in Oramed Pharmaceuticals Inc  as shares are moving today on volatility 0.66% or $0.04 from the open.'
p6
aS"Here's Where Oramed Fits Into The Diabetes Space Seeking Alpha - Feb 17, 2017 One company that is attempting to do exactly that right now, and that looks to have an attractive pitch, is Oramed Pharmaceuticals Inc. . The company's CEO, Nadav Kidron, featured on CNBC's Squawk Box earlier this week and highlighted&nbsp;..."
p7
aS"Oramed Pharmaceuticals'  CEO Nadav Kidron Hosts Phase IIb Clinical ... Seeking Alpha - Jul 29, 2016 I encourage you to review the cautionary language about forward-looking statements in today's press release, which can be found on Oramed's website, as well as the Company's filings with the Securities and Exchange Commission including, without&nbsp;..."
p8
aS"Weekly Biotech Report Part II, Oramed Pharmaceuticals, Inc.  Market Exclusive - May 23, 2016 In the forward looking element of last week's Market Exclusive biotechnology weekly report, we discussed two companies that were set to report key data during the then week ahead.Early Trials Show an Insulin Pill Can Lower Diabetics' Blood Sugar Levels - ScienceAlert"
p9
aS'Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50000000 ... PR Newswire  - Jul 7, 2015 Oramed Pharmaceuticals Inc.  , a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has signed a non-binding Letter of Intent  for an&nbsp;...'
p10
a.